放射生物学模型与指数在计划比较评估中的整合:VMAT与3D-CRT在NSCLC患者中的对比研究
本研究开发了一种计算放射生物学终点和综合指数的算法,并用于比较局部晚期非小细胞肺癌(NSCLC)患者中容积旋转调强放疗(VMAT)与三维适形放疗(3D-CRT)的差异。研究纳入25例既往接受3D-CRT的患者,基于原CT和感兴趣区生成VMAT计划,计算肿瘤控制概率(TCP)、正常组织并发症概率(NTCP)及复合指数。结果显示3D-CRT的TCP更优,而VMAT在食管、脊髓、心脏/灌注缺损的NTCP及发病率指数、心肺毒性指数(CPTI)、治疗增益(TG)方面更优,UTCP有优于3D-CRT的趋势。
要点
- 3D-CRT的TCP优于VMAT(12.62% vs 11.71%,P < .001)。
- VMAT在食管、脊髓、心脏/灌注缺损的NTCP及MI、CPTI、TG方面更优。
- 两组间肺NTCP和心脏/心包炎NTCP无差异。
核心结论
- 放射生物学算法和综合指数可用于计划比较评估,并显示VMAT相较于3D-CRT具有优势。
研究设计与样本
- 研究纳入25例2010年1月1日至2014年12月31日期间在本中心接受3D-CRT的局部晚期NSCLC患者,基于原CT和感兴趣区生成VMAT计划,使用相同剂量体积约束工作表,采用R语言编写计算引擎计算放射生物学终点和综合指数。
主要发现
- 3D-CRT的TCP为12.62%,VMAT为11.71%,差异有统计学意义(P < .001)。
- VMAT的食管NTCP为4.45%,3D-CRT为7.39%(P = .02);脊髓NTCP分别为0.001%和0.009%(P = .001);心脏/灌注缺损NTCP分别为44.57%和56.42%(P = .016)。
- 肺NTCP在VMAT和3D-CRT分别为6.27%和7.62%(P = .221),心脏/心包炎NTCP分别为0.001%和0.15%(P = .129),差异无统计学意义。
- VMAT的发病率指数为11.06%,3D-CRT为14.31%(P = 0.01);CPTI分别为47.59%和59.41%(P = .03);TG差异有统计学意义(P = .035);UTCP分别为5.89和4.75,差异接近统计学意义(P = .057)。
关键数值与推荐
- TCP:3D-CRT 12.62% vs VMAT 11.71%(P < .001)。
- 食管NTCP:VMAT 4.45% vs 3D-CRT 7.39%(P = .02);脊髓NTCP:VMAT 0.001% vs 3D-CRT 0.009%(P = .001);心脏/灌注缺损NTCP:VMAT 44.57% vs 3D-CRT 56.42%(P = .016)。
- 肺NTCP:VMAT 6.27% vs 3D-CRT 7.62%(P = .221);心脏/心包炎NTCP:VMAT 0.001% vs 3D-CRT 0.15%(P = .129)。
- 发病率指数:VMAT 11.06% vs 3D-CRT 14.31%(P = 0.01);CPTI:VMAT 47.59% vs 3D-CRT 59.41%(P = .03);TG差异P = .035;UTCP:VMAT 5.89 vs 3D-CRT 4.75(P = .057)。
临床怎么用
- 在局部晚期NSCLC的放疗计划比较中,可结合放射生物学模型和综合指数评估VMAT与3D-CRT的利弊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this article was to generate an algorithm to calculate radiobiological endpoints and composite indices and use them to compare volumetric modulated arc therapy (VMAT) and 3-dimensional conformal radiation therapy (3D-CRT) techniques in patients with locally advanced non-small cell lung cancer. METHODS AND MATERIALS: The study included 25 patients with locally advanced non-small cell lung cancer treated with 3D-CRT at our center between January 1, 2010, and December 31, 2014. The planner generated VMAT plans using clones of the original computed tomography scans and regions of interest volumes, which did not include the original 3D plans. Both 3D-CRT and VMAT plans were generated using the same dose-volume constraint worksheet. The dose-volume histogram parameters for planning target volume and relevant organs at risk (OAR) were reviewed. The calculation engine was written in the R programming language; the user interface was developed with the "shiny" R Web library. Dose-volume histogram data were imported into the calculation engine and tumor control probability (TCP), normal tissue complication probability (NTCP), composite cardiopulmonary toxicity index (CPTI), morbidity index: MI = ∑j = 1#ofrelevantOARs(wj ∗ NTCPj), uncomplicated TCP (UTCP=TCP∗∏k=1#ofOARs1-NTCPK100, and therapeutic gain (TG): ie, TG = TCP ∗ (100 - MI) were calculated. RESULTS: TCP was better with 3D-CRT (12.62% vs 11.71%, P < .001), whereas VMAT demonstrated superior NTCP esophagus (4.45% vs 7.39%, P = .02). NTCP spinal cord (0.001% vs 0.009%, P = .001), and NTCP heart/perfusion defect (44.57% vs 56.42%, P = .016). There was no difference in NTCP lung (6.27% vs 7.62%, P = .221) and NTCP heart/pericarditis (0.001% vs 0.15%, P = .129) between 2 techniques. VMAT showed substantial improvement in morbidity index (11.06% vs. 14.31%, P = 0.01), CPTI (47.59% vs 59.41%, P = .03), TG (P = .035), and trend toward superiority in UTCP (5.89 vs 4.75, P=.057). CONCLUSION: The study highlights the utility of the radiobiological algorithm and summary indices in comparative plan evaluation and demonstrates benefits of VMAT over 3D-CRT.
引用
- Roy S, Badragan I, Ahmed SN, et al. Integration of radiobiological modeling and indices in comparative plan evaluation: A study comparing VMAT and 3D-CRT in patients with NSCLC. Pract Radiat Oncol. 2018. PMID: 29703705. doi:10.1016/j.prro.2018.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。